Health Equity, Federalism, and Cannabis Policy by Huberfeld, Nicole
Boston University School of Law 
Scholarly Commons at Boston University School of Law 
Faculty Scholarship 
5-2021 
Health Equity, Federalism, and Cannabis Policy 
Nicole Huberfeld 
Follow this and additional works at: https://scholarship.law.bu.edu/faculty_scholarship 
 
897 




Cannabis policy is a story of complexity and dynamism laced with tension 
and inequity. Policy makers’ views are rapidly changing, reflected by many bills 
sitting before Congress. This Essay considers three of the major bills that have 
a more comprehensive approach to cannabis. These bills also take different 
approaches to the flipped federalism that could occur if the federal government 
were to suddenly decriminalize cannabis. The Essay next considers the state law 
landscape and compares it to Medicaid expansion under the Affordable Care 
Act, drawing a comparison to learn health equity lessons from recent health 
reform efforts. Federal legislation is needed and should at least reschedule 
marijuana under the Controlled Substances Act. But it should also create a 
legalization baseline that would improve the underlying determinants of health, 
which have been deeply affected by the fifty-year war on drugs. Additionally, 
Congress should consider how to make states into policy-making partners to 
more quickly entrench such a substantial policy shift. While states have been 
leading in cannabis policy making through the last decade, federal 
responsibility for major aspects of the legal landscape suggests that a federal 
response should take the lead and invite states to partner. Otherwise, the 
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INTRODUCTION 
One in three Americans live in states where individuals over the age of 
twenty-one can legally use cannabis,1 reflecting a decade-long trend of 
decriminalization and legalization of marijuana for medical purposes, 
recreational purposes, or both.2 Just eight years ago, only two states (Colorado 
and Washington) had legalized marijuana for recreational use.3 The 
decriminalization and legalization of cannabis has come about through state 
voter ballot initiatives and legislative actions. For all of the recent policy 
movement, the goals in taking such action remain somewhat opaque. Is the 
primary driver criminal justice reform? Mitigating harms to communities 
targeted by the war on drugs? Safe medical access? Tax collection? The reasons 
are as varied as the states’ laws, which stand in tension with federal law—
namely, the Controlled Substances Act (“CSA”), which formally prohibits every 
use of marijuana.4 
In 1996, California voters began the contemporary path to decriminalization 
through the Compassionate Use Act, which facilitated medical marijuana use.5 
Opinion polls indicate that regardless of political party affiliation, the public now 
generally supports cannabis reform, with the greatest support for medical 
 
1 Natalie Fertig & Mona Zhang, 1 in 3 Americans Now Lives in a State Where Recreational 
Marijuana Is Legal, POLITICO (Nov. 4, 2020, 5:31 AM), https://www.politico.com 
/news/2020/11/04/1-in-3-americans-lives-where-recreational-marijuana-legal-434004 
[https://perma.cc/SX3X-553B]. 
2 Marijuana is a common but controversial term, as its origins appear to reflect stoking of 
anti-Mexican prejudice in the 1930s. See Christopher Ingraham, ‘Marijuana’ or 
‘Marihuana’? It’s All Weed to the DEA, WASH. POST (Dec. 16, 2016, 7:00 AM), 
https://www.washingtonpost.com/news/wonk/wp/2016/12/16/marijuana-or-marihuana-its-
all-weed-to-the-dea/. Cannabis is the scientific terminology for the plant. Cannabis 
(Marijuana) and Cannabinoids: What You Need to Know, NAT’L CTR. FOR COMPLEMENTARY 
& INTEGRATIVE HEALTH [hereinafter Cannabis and Cannabinoids], 
https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-
know [https://perma.cc/ET7D-SUYQ] (last updated Nov. 2019). Advocates seeking to 
eliminate ties to the fraught and racialized history of drug regulation tend to favor the term 
cannabis, but some advocates still use the term marijuana. See Mariah Woelfel, Pot? Weed? 
Marijuana? What Should We Call It?, NPR (Sept. 19, 2019), https://www.npr.org 
/local/309/2019/09/19/762044859/pot-weed-marijuana-what-should-we-call-it [https:// 
perma.cc/VQ9M-C64D]. This Essay uses both, reflecting current division in terminology 
preference. See id. 
3 Christina Ng, Abby Phillips & Clayton Sandell, Colorado, Washington Become First 
States to Legalize Recreational Marijuana, ABC NEWS (Nov. 6, 2012, 11:49 AM), 
https://abcnews.go.com/Politics/OTUS/colorado-washington-states-legalize-recreational-
marijuana/story?id=17652774 [https://perma.cc/5SPK-DSGY]. 
4 21 U.S.C. §§ 801-904. 
5 See CAL. HEALTH & SAFETY CODE § 11362.5 (West 2021); see also Gonzales v. Raich, 
545 U.S. 1, 32-33 (2005); George J. Annas, Reefer Madness – The Federal Response to 
California’s Medical-Marijuana Law, 337 NEW ENG. J. MED. 435, 435-38 (1997) (discussing 
the Compassionate Use Act and efforts to reschedule marijuana to Schedule II, which began 
shortly after the CSA was enacted). 
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marijuana laws.6 Yet, a disconnect seems to exist between public support for 
medical marijuana and the reality of deeply disparate drug-enforcement efforts. 
Marijuana-related arrests comprise more than 40% of all drug arrests in the 
United States, and Black Americans are nearly four times more likely to be 
arrested for marijuana possession than white Americans.7 This deep disparity 
exists even in states that have decriminalized or legalized marijuana possession.8 
Medical marijuana laws create an exception to criminal rules, a policy choice 
that does not necessitate developing a comprehensive regulatory regime. State 
decriminalization of cannabis is sometimes accompanied by legalization and 
regulation,9 and each state has addressed decriminalization/legalization 
somewhat differently. The spectrum of approaches ranges from permitting only 
noncommercial medical use, to full legalization for adults with attendant 
licensure schemes for new businesses, to expungement of criminal records, to 
opportunities for communities harmed by the war on drugs, to decriminalization 
of other drugs in addition to cannabis.10 States appear to be learning from one 
 
6 See generally John Hudak & Christine Stenglein, Public Opinion and America’s 
Experimentation with Cannabis Reform, in MARIJUANA FEDERALISM 15, 31 (Jonathan H. 
Adler ed., 2020). 
7 ACLU, A TALE OF TWO COUNTRIES: RACIALLY TARGETED ARRESTS IN THE ERA OF 
MARIJUANA REFORM 7 (2020), https://www.aclu.org/sites/default/files/field_document/tale 
_of_two_countries_racially_targeted_arrests_in_the_era_of_marijuana_reform_revised_7.1.
20_0.pdf [https://perma.cc/8HHN-KE8Q]. The report summarizes: 
In 2018, there were almost 700,000 marijuana arrests, which accounted for more than 
43% of all drug arrests. In fact, in 2018, police made more marijuana arrests than for all 
violent crimes combined, according to the FBI. Further, it is not clear that marijuana 
arrests are trending down—they have actually risen in the past few years, with almost 
100,000 more arrests in 2018 than 2015. This rise in marijuana arrests has been driven 
by states in which marijuana is still illegal, whereas between 2010 and 2018, marijuana 
arrests were significantly lower in states that had legalized and went down modestly in 
states that had decriminalized. Consistent with our previous report, the majority of 
marijuana arrests—nine out of every 10—were for possession. 
 Equally as troubling, this report finds that stark racial disparities in marijuana 
possession arrests have remained unchanged nationwide. On average, a Black person is 
3.64 times more likely to be arrested for marijuana possession than a white person, even 
though Black and white people use marijuana at similar rates. 
Id. at 5. 
8 Id. at 8, 32 tbl.7 (noting that state-by-state arrest rates vary widely, with some states as 
much as ten times more likely to arrest Black people for marijuana-related offenses). 
9 See Angela Dills, Sietse Goffard & Jeffrey Miron, The Effect of State Marijuana 
Legalizations: An Update, in MARIJUANA FEDERALISM, supra note 6, at 35, 37-42 (detailing 
history and variety of state actions decriminalizing and legalizing cannabis). 
10 Jonathan H. Adler, Introduction to MARIJUANA FEDERALISM, supra note 6, at 1, 5-7 
(summarizing progression and range of state laws addressing cannabis use); see also Scott 
Akins & Clayton Mosher, Oregon Just Decriminalized All Drugs – Here’s Why Voters Passed 
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another’s statutory schemes, engaging in “horizontal federalism.”11 Unto itself, 
this horizontal federalism is not inherently positive, as states do not always 
engage in evidence-based policy making, but it may help states and the 
businesses dealing with new legalization regimes to navigate rough federal 
waters. 
State legalization laws conflict directly with the federal statutory scheme of 
the CSA, which schedules marijuana as an illegal substance with no legal 
exceptions because it is deemed to have no medical benefits.12 While executive 
policies have buffered this conflict, federal law remains hostile to marijuana 
used or sold for any purpose.13 This approach contradicts evidence in the 
medical literature indicating that cannabis has multiple medical purposes that 
merit deeper study.14 That deeper study is hampered by federal law prohibiting 
any use of marijuana, as federal funds are largely unavailable for scientific 
studies of illegal substances. But health concerns run deeper than marijuana’s 
medical uses. 
The decriminalization/legalization movement has been marching in one 
direction rather rapidly, and federal legislative action seems more likely than 
ever before. The Biden Administration has signaled support for 
decriminalization,15 and several bills that reschedule marijuana sit before 
Congress.16 Federal marijuana rescheduling would begin to mitigate the harms 
of decades of discriminatory drug-related arrests and convictions. 
 
11 See Abbe R. Gluck & Nicole Huberfeld, What Is Federalism in Healthcare For?, 70 
STAN. L. Rev. 1689, 1694, 1700, 1733-46, 1772-76 (2018) (discussing horizontal federalism 
in context of Medicaid expansion and health insurance exchange implementation under the 
ACA). 
12 21 U.S.C. § 812(b)-(c). 
13 The Ogden and Cole Memoranda to Department of Justice Attorneys limited 
prosecution for marijuana possession so long as the possession was consistent with state law. 
Memorandum from David W. Ogden, Deputy Att’y Gen., DOJ, to Selected U.S. Att’ys (Oct. 
19, 2009) [hereinafter Ogden Memorandum], www.justice.gov/sites/default 
/files/opa/legacy/2009/10/19/medical-marijuana.pdf [https://perma.cc/4CBU-KMUC]; 
Memorandum from James M. Cole, Deputy Att’y Gen., DOJ, to U.S. Att’ys (June 29, 2011) 
[hereinafter Cole Memorandum], https://www.justice.gov/sites/default 
/files/oip/legacy/2014/07/23/dag-guidance-2011-for-medical-marijuana-use.pdf [https:// 
perma.cc/BX5K-XMJS]. Federal conflict is resolved slightly by the appropriation rider that 
creates a presumption against cannabis prosecution. See Consolidated Appropriations Act, 
2020, Pub. L. No. 116-93, § 531, 133 Stat. 2317, 2431. But the conflict between state and 
federal law is significant enough that the Congressional Research Service wrote a monograph. 
See TODD GARVEY, CONG. RSCH. SERV., R42398, MEDICAL MARIJUANA: THE SUPREMACY 
CLAUSE, FEDERALISM, AND THE INTERPLAY BETWEEN STATE AND FEDERAL LAWS (2012), 
https://fas.org/sgp/crs/misc/R42398.pdf [https://perma.cc/8W87-M4XU]. 
14 See Cannabis and Cannabinoids, supra note 2 (describing medically indicated uses for 
cannabis). 
15 Tim Craig, Biden, Once a Warrior in the ‘War on Drugs,’ May Slowly Retreat, WASH. 
POST (Jan. 11, 2021, 8:00 AM), https://www.washingtonpost.com/politics/2021/01/11/biden-
war-on-drugs/. 
16 See, e.g., Marijuana 1-to-3 Act of 2021, H.R. 365, 117th Cong. (2021). 
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Decriminalization is just the beginning; legalization offers an opportunity to 
craft a statutory scheme that addresses the many goals reflected in state laws so 
far. The war on drugs has exacerbated nearly every underlying determinant of 
health—from incarceration, to wealth, to education, to political participation17—
and federal legalization offers an opportunity to address health equity more 
comprehensively than the somewhat narrow issue of medical marijuana. 
Cannabis policy is a story of complexity and dynamism but also tension and 
inequity. In recognition that policy makers’ views are rapidly changing, Part I 
of this Essay first considers three of the major bills currently before Congress, 
chosen for their more comprehensive approach to cannabis as well as the ways 
that they address federalism concerns. Next, Part I considers the state law 
landscape and compares it to Medicaid expansion under the Affordable Care Act 
(“ACA”), drawing a comparison to learn health equity lessons from recent health 
reform efforts. Part II concludes that federal legislation should reschedule 
marijuana under the CSA but should also create a legalization baseline that 
would improve the underlying determinants of health so deeply affected by the 
fifty-year war on drugs. Further, Congress should consider what it would take to 
make states agreeable partners if it is to succeed with a substantial policy shift. 
While states have been leading over the last several years, federal responsibility 
for the major features of the legal landscape suggests that a federal response 
should account for the need to have states engage with federal policy. Otherwise, 
state law variability will continue to harm the health of already vulnerable 
populations. 
I. DECRIMINALIZATION, LEGALIZATION, AND FEDERAL/STATE CONFLICT 
Cannabis sits at a cross section of key policy matters, including medicine, 
public health, criminal justice, constitutional interpretation, and democratic 
engagement. These matters became more pronounced during 2020, a year in 
which health and economic disparities were elevated through the COVID-19 
pandemic, the Black Lives Matter movement, and the presidential election.18 
These are issues that raise national questions and are shaped by major federal 
law. The national questions have been addressed to a degree through executive 
action, but until recently, Congress has not appeared willing to amend the CSA 
or to otherwise deal with increasingly prominent cannabis questions. 
A. Federal Landscape 
The CSA classifies marijuana, along with other substances such as peyote, 
LSD, and heroin, as a Schedule I drug.19 This means the formal federal policy is 
that marijuana has no recognized medical use, a high potential for abuse, and the 
 
17 See generally MARC MAUER & RYAN S. KING, SENT’G PROJECT, A 25-YEAR QUAGMIRE: 
THE WAR ON DRUGS AND ITS IMPACT ON AMERICAN SOCIETY (2007). 
18 See Emily Badger, Inequality Was Never So Visible as in 2020. What Did We Learn?, 
N.Y. TIMES, Dec. 29, 2020, at B3. 
19 21 U.S.C. § 812(c) Schedule I. 
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possibility of dependence.20 While some states agree with this approach and 
choose to work with federal law enforcement, states are not obligated to enforce 
federal laws.21 Those states that have enacted new laws decriminalizing and 
legalizing cannabis do so under an umbrella of federal illegality, creating risk 
for those who use cannabis and those who sell it, especially in states that move 
beyond decriminalization to legalization with a regulatory scheme. During the 
Obama Administration, the Cole and Ogden Memoranda instructed U.S. 
Attorneys to refrain from prosecuting individuals in compliance with state laws 
that legalize and regulate cannabis, creating a sort of safe harbor.22 But this 
subregulatory guidance was reversed early on in the Trump Administration and 
became a source of controversy and uncertainty.23 
Perhaps tellingly, the fifty-year-old CSA has come under fire from key policy 
makers at both the federal and state levels. Despite long-standing reluctance to 
revisit the CSA’s schedule system, a number of major bills addressing cannabis 
policy are before Congress, three of which are discussed here. The most 
comprehensive, sponsored by Senator Cory Booker for several years, is called 
the Marijuana Justice Act.24 This bill amends the CSA, decriminalizing cannabis 
by removing “marihuana” and other references to cannabinoids from the list of 
scheduled substances and eliminating criminal penalties for individuals who 
import, export, manufacture, distribute, or possess with intent to distribute 
marijuana.25 Following through on decriminalization, the bill instructs federal 
courts to expunge convictions for marijuana use and possession.26 Notably, the 
bill would reduce federal funding for prison or jail construction for any state that 
has not legalized marijuana and that has a disproportionate arrest or 
incarceration rate for marijuana-related criminal offenses.27 It also establishes 
the Community Reinvestment Fund, which would offer grants to support 
communities most affected by the war on drugs by providing job training and 
 
20 See Drug Scheduling, U.S. DRUG ENF’T ADMIN., https://www.dea.gov/drug-scheduling 
[https://perma.cc/3KBA-D9VW] (last visited Apr. 13, 2021). 
21 See Printz v. United States, 521 U.S. 898, 928 (1997) (holding that state officials cannot 
be “dragooned” into enforcing federal laws (quoting Mack v. United States, 66 F.3d 1025, 
1035 (9th Cir. 1995) (Fernandez, J., concurring and dissenting))); New York v. United States, 
505 U.S. 144, 175-76 (1992) (holding that federalism prevents the federal government from 
“commandeer[ing]” states for federal regulatory purposes). 
22 Cole Memorandum, supra note 13; Ogden Memorandum, supra note 13. 
23 See Memorandum from Jefferson B. Sessions, III, Att’y Gen., DOJ, to All U.S. Att’ys 
(Jan. 4, 2018), https://www.justice.gov/opa/press-release/file/1022196/download 
[https://perma.cc/CN3F-5Z8N]. 
24 Marijuana Justice Act of 2019, S. 597, 116th Cong. (2019). 
25 Id. § 2. 
26 Id. § 3(c). 
27 Id. § 3. The Marijuana Justice Act defines disproportionate arrest rate as occurring when 
“the percentage of minority individuals arrested for a marijuana related offense in a State is 
higher than the percentage of the non-minority individual population of the State, as 
determined by the most recent census data.” Id. § 3(a)(2)(A). 
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reentry services, paying for expenses related to expungement, funding public 
libraries and community centers, paying for youth programming, and creating 
health education programs, among other programs.28 In addition to this bill, 
Senator Booker has cosponsored other, less comprehensive bills, such as the Fair 
Chance to Compete for Jobs Act, which prohibits the federal government from 
inquiring about criminal convictions in the hiring process.29 The Record 
Expungement Designed to Enhance Employment Act—reintroduced in 2019 
with an identical House bill called the Next Step Act30—would seal criminal 
records for adults and juveniles, expunge some juvenile records, and lift the 
federal ban on Supplemental Nutrition Assistance Program (“SNAP”) and 
Temporary Assistance for Needy Families (“TANF”) benefits for people 
convicted of nonviolent drug-related crimes.31 The Compassionate Access, 
Research Expansion, and Respect States Act (“CARES Act”) would legalize 
medical marijuana.32 
The Marijuana Opportunity Reinvestment & Expungement Act (“MORE 
Act”), sponsored in the Senate by then-Senator Kamala Harris33 and passed by 
the House on December 4, 2020, also decriminalizes cannabis by amending the 
CSA and removing marijuana from Schedule I.34 Senator Booker is a cosponsor, 
and like the Marijuana Justice Act, this bill eliminates criminal penalties for an 
 
28 Id. § 4. 
29 Fair Chance to Compete for Jobs Act of 2019, S. 387, 116th Cong. (2019). 
30 Next Step Act of 2019, H.R. 1893, 116th Cong. (2019). 
31 Next Step Act of 2019, S. 697, 116th Cong. (2019). 
32 CARES Act of 2017, S. 1764, 115th Cong. (2017). Senator Booker introduced this bill 
in 2017 to counteract then–Attorney General Jeff Sessions’s goal of renewing DOJ 
prosecution in all drug cases, including those involving marijuana. See Matt Laslo, Medical 
Marijuana Bill Aims to Fight Jeff Sessions’ Renewed War on Drugs, ROLLING STONE (June 
16, 2017, 3:05 PM), https://www.rollingstone.com/politics/politics-news/medical-marijuana-
bill-aims-to-fight-jeff-sessions-renewed-war-on-drugs-194046. 
33 MORE Act of 2019, S. 2227, 116th Cong. (2019). 
34 MORE Act of 2020, H.R. 3884, 116th Cong. (2020); Actions Overview H.R. 3884 — 
116th Congress (2019-2020), CONGRESS.GOV, https://www.congress.gov/bill/116th-
congress/house-bill/3884/actions [https://perma.cc/RY34-DU3B] (last visited Apr. 13, 2021). 
Former Massachusetts Cannabis Control Commissioner Shaleen Title expressed concern that 
this bill is a compromise. 
What happens with federal legalization obviously depends on . . . who controls the [US] 
Senate. In general, though, it’s hard to be excited about Biden. He was the only serious 
Democratic candidate who didn’t support legalization and seems to think putting drug 
users in mandatory treatment is a policy to be proud of. . . . 
 And based on what we saw recently with the MORE Act, I’m not sure today’s federal 
legalization bills fully reflect the lessons we’ve learned at the state level. . . . Obviously 
it was historic for the [US] House to pass that bill and it would stop some of the arrests 
that have devastated people, but we’ve done too much work and come too far to just 
settle. 
Dan Adams, Q&A with Outgoing Cannabis Commissioner Shaleen Title, BOS. GLOBE (Dec. 
29, 2020, 1:12 PM), https://www.bostonglobe.com/2020/12/29/marijuana/qa-with-outgoing-
cannabis-commissioner-shaleen-title/ (second and fifth alterations in original). 
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individual who manufactures, distributes, or possesses marijuana and rectifies 
some historical prejudices by replacing statutory references to “marijuana” and 
“marihuana” with “cannabis.”35 The bill also seeks to address economic equity 
issues: for example, it requires the Bureau of Labor Statistics to publish 
demographic data on cannabis business owners and employees; establishes a 
fund to support programs and services for individuals and businesses in 
communities impacted by the war on drugs, paid for in part by a 5% tax on 
cannabis products; and makes Small Business Administration loans and services 
available to cannabis-related businesses or service providers.36 The MORE Act 
prohibits denial of federal public benefits and denial of benefits and protections 
under immigration laws on the basis of cannabis-related convictions.37 This bill 
also establishes a process to expunge convictions and conduct sentence review 
hearings related to federal offenses.38 The MORE Act is nearly as 
comprehensive as Senator Booker’s Marijuana Justice Act, but it lacks the 
automatic expungement provision and does not support communities as 
robustly. It also does not penalize states that choose not to follow the amended 
federal approach. 
The Marijuana Freedom and Opportunity Act sponsored by Senator Chuck 
Schumer also amends the CSA and decriminalizes marijuana by removing it 
from Schedule I and eliminating criminal penalties for use and possession.39 
Similar to the MORE Act, this bill establishes a fund, this one targeted to 
assisting women- and minority-owned cannabis businesses.40 The bill requires 
federal research into the impact of cannabis use on highway safety and public 
health, authorizes federal restrictions on the marketing of cannabis-related 
products, and provides federal funds to state and local governments to expunge 
or seal convictions for cannabis possession.41 The bill has another difference, 
stating: “Nothing in this Act, or an amendment made by this Act, may be 
construed to modify the authority of the Federal Government to prevent 
marijuana trafficking from States that have legalized marijuana to those that 
have not.”42 This provision is explained by the bill’s press release, which 
asserted that the proposal would respect states’ rights and “allow[] states to 
continue to function as laboratories of democracy and ultimately decide how 
they will treat marijuana possession.”43  
 
35 H.R. 3884 § 3. 
36 Id. §§ 4-6. 
37 Id. §§ 8-9. 
38 Id. § 10. 
39 Marijuana Freedom and Opportunity Act, S. 1552, 116th Cong. (2019). 
40 Id. § 3(c). 
41 Id. §§ 4-7. 
42 Id. § 8. 
43 Press Release, Senate Democrats, Schumer Introduces Marijuana Freedom and 
Opportunity Act - New Legislation Would Decriminalize Marijuana at Federal Level (June 
27, 2018), https://www.democrats.senate.gov/newsroom/press-releases/schumer-introduces-
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The three major bills—the Marijuana Justice Act, MORE Act, and Marijuana 
Freedom and Opportunity Act—represent efforts at both decriminalization and 
legalization, and they present a range of federal and state governance 
possibilities. The Marijuana Justice Act addresses states’ key role in disparate 
arrest and conviction rates related to marijuana, which supports the new federal 
standards that the bill would create using monetary penalties.44 Offering new 
funding or withholding federal funding is a common congressional tool for 
influencing state policy choices. This indirect regulatory approach does not run 
afoul of the coercion doctrine expressed in NFIB v. Sebelius,45 as only 10% of 
federal funds for prison and jail construction would be jeopardized by state 
actions continuing prejudicial drug law enforcement.46 It is difficult to predict 
whether this penalty could be high enough to influence state policy choice. 
Though, as South Dakota v. Dole47 indicated, a mere 5% reduction in funding 
may be enough for states to feel pressure to change their laws.48 
Any of these bills could create a flipped federalism dynamic from current law. 
Now, the federal government forbids marijuana use and sales entirely, but nearly 
two-thirds of states have decided to decriminalize and legalize cannabis.49 If 
Congress were to amend the CSA to decriminalize or legalize marijuana, then 
the states that retain criminal penalties become the outliers facing a conflict with 
federal law. The states’ choice (or inaction) would continue the complexity of 
the current layered drug law regime and would keep the door open to 
significantly more drug arrests and convictions in those states. 
The MORE Act and the Marijuana Freedom and Opportunity Act amend the 
federal baseline but do little to address this possibility that states could continue 
with opposing or conflicting policies. These two bills very likely do not offer 
enough incentive to states that resist decriminalization. Additionally, the 
Schumer-sponsored Marijuana Freedom and Opportunity Act contains a rule of 
construction retaining authority for the federal government to “prevent 
marijuana trafficking from States that have legalized marijuana to those that 
have not.”50 This provision acknowledges that states may continue to criminalize 
most or all cannabis use after the federal government decriminalizes, which 
would conflict with the policy goals of an amended CSA. Federalism scholars 




44 Marijuana Justice Act of 2019, S. 597, 116th Cong. § 3(b) (2019). 
45 567 U.S. 519, 579 (2012) (plurality opinion). 
46 See id.; see also S. 597 § 3(b)(1). 
47 483 U.S. 203 (1987). 
48 Id. at 211. 
49 Deep Dive: Marijuana, NAT’L CONF. OF STATE LEGISLATURES, https://www.ncsl.org 
/bookstore/state-legislatures-magazine/marijuana-deep-dive.aspx [https://perma.cc/8ZZ2-
JKMY] (last visited Apr. 13, 2021). 
50 Marijuana Freedom and Opportunity Act, S. 1552, 116th Cong. § 8 (2019). 
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state choosing a policy that suits its priorities. The trouble is that such 
experiments sometimes fail even with seemingly optimal state laws in place. 
B. State Experiments, Variability, and Equity Concerns 
The notion that “competitive federalism” drives state policy innovation is 
undercut by the near impossibility that low-income people will move to or from 
their residence based on policy experimentation.51 To the extent that people of 
color are more likely to be lower income and therefore less likely to be able to 
vote with their feet,52 this means that the people most affected by states’ cannabis 
laws are also the least likely to be able to move based on policy preferences. 
When Justice Brandeis’s iconic federalism dissent is quoted, the second part 
of his observation is often overlooked: “It is one of the happy incidents of the 
federal system that a single courageous State may . . . serve as a laboratory; and 
try novel social and economic experiments without risk to the rest of the 
country.”53 In the modern era, the likelihood that a given policy experiment will 
not pose risks that spill over to neighbor states or the nation as a whole is quite 
limited. 
The Massachusetts community contracting program offers a cautionary tale. 
In 2016, when Massachusetts legalized marijuana possession, the state created a 
plan for not only ceasing arrests but also repairing the harms of the war on drugs. 
Massachusetts’s law required equity in commercial opportunities, 
foregrounding disproportionately harmed communities in the newly created 
legal cannabis regime.54 But multiple town officials became the subject of a 
federal bribery investigation when they appeared to get greedy in the dispensary 
contracting process and demanded cash from start-up cannabis businesses.55 In 
a state that takes health policy seriously—famously having been first to craft 
universal insurance coverage—it is notable that the outgoing cannabis 
commissioner described the reparative design of the state’s law as an ongoing 
 
51 See, e.g., Adler, supra note 10, at 5-6; see also JAMILA MICHENER, FRAGMENTED 
DEMOCRACY: MEDICAID, FEDERALISM, AND UNEQUAL POLITICS 4-5 (2018) (reporting that low-
income people become immobilized due to reliance on social programs like Medicaid as it 
exists in a particular state); Gluck & Huberfeld, supra note 11, at 1722-24 (noting that state 
policy action in health care can result in a race to the bottom because states cannot self fund). 
52 Ethnic and Racial Minorities & Socioeconomic Status, AM. PSYCH. ASS’N (July 2017), 
https://www.apa.org/pi/ses/resources/publications/minorities [https://perma.cc/ZZM8-
K2N6]. 
53 New State Ice Co. v. Liebmann, 285 U.S. 262, 311 (1932) (Brandeis, J., dissenting) 
(emphasis added). 
54 See Adams, supra note 34 (discussing Cannabis Control Commission’s challenges and 
successes, including goal of achieving equity). 
55 Dan Adams, Felicia Gans & Naomi Martin, Federal Grand Jury Investigating 
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challenge.56 Other states have followed this reparation-oriented model—
recently New Jersey, though it softened the equity language of the Massachusetts 
law.57 
Practically speaking, it is unrealistic to think that one state would be able to 
keep legalized drugs entirely within its borders, as the Supreme Court 
acknowledged in Gonzales v. Raich.58 Congress controls this national and 
international market in cannabis through the commerce power because the 
market is almost never purely local. The person growing five pot plants on her 
windowsill is but one transaction away from the national market. In other words, 
to choose policy approaches as if states can contain their cannabis policies is to 
deny the reality of modern markets. Additionally, state control of a policy matter 
with deeply disparate and life-long implications for those affected by local laws 
is one way that disparities have been allowed to continue. To underscore the 
wide assortment of state approaches to cannabis law, and the implications of this 






















56 See Adams, supra note 34. 
57 See New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace 
Modernization Act, S. 21, 219th Leg., Reg. Sess. (N.J. 2020). 
58 545 U.S. 1, 32 (2005). 
59 See ACLU, supra note 7, at 7-9 (reporting state-by-state variability in cannabis laws, 
arrests, and conviction rates). 
60 State Medical Marijuana Laws, NAT’L CONF. OF STATE LEGISLATURES, 
https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx 
[https://perma.cc/T47D-XBNS] (last updated Apr. 5, 2021). 
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It is striking that the cannabis law map looks much like the state Medicaid 
expansion map:61 
 





61 Status of State Medicaid Expansion Decisions: Interactive Map, KAISER FAM. FOUND., 
https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-
interactive-map/ [https://perma.cc/7B8H-7BZH] (last updated Apr. 13, 2021). 
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If health equity is a national goal—which the federal government, in passing laws 
like the ACA, has indicated it is62—then leaving major policy change to the states 
invites policy inconsistency that may be not only suboptimal but also harmful. These 
maps provide snapshots that illustrate the significance of setting federal baselines if 
one goal of cannabis decriminalization is to mitigate the war on drugs’s impact on 
health. The war on drugs introduced a national statutory scheme designed to deter 
drug use with roots in racism. Fifty years of unceasing drug use across all 
demographics, but increasing incarceration of Black and Hispanic populations,63 
indicates that this “war” against President Nixon’s “public enemy number one”64 
should not have linked drugs and addiction with crime but rather with health care 
and social determinants of health. Senator Booker’s bill does this by withholding 
federal funds from states that continue to discriminate in drug law implementation.65 
Other bills allow states to continue to criminalize cannabis, hoping that the federal 
push will lead by example. Health reform efforts indicate that this may not be enough 
where deep disparities are entrenched. 
II. CAN WE LEARN FROM OTHER REFORM EFFORTS? 
President Joe Biden has voiced some support for decriminalizing cannabis 
possession; however, his position while campaigning was that states should continue 
to set their own policies.66 Scholars have written that this creates a federalism 
quandary for deciphering which aspects of federal law are supreme and which 
aspects of state law conflicting with federal law are permissible.67 This quandary 
 
62 See Affordable Care Act (ACA), HEALTHCARE.GOV, https://www.healthcare.gov 
/glossary/affordable-care-act/ [https://perma.cc/7P5X-36UF] (last visited Apr. 13, 2021). 




64 Much has been written on this topic. For a quick summary, see Emily Dufton, The War 
on Drugs: How President Nixon Tied Addiction to Crime, ATLANTIC (Mar. 26, 2012), 
https://www.theatlantic.com/health/archive/2012/03/the-war-on-drugs-how-president-nixon-
tied-addiction-to-crime/254319/. 
65 Marijuana Justice Act of 2019, S. 597, 116th Cong. § 3(b) (2019). 
66 A Biden spokesperson stated that 
[Biden] supports decriminalizing marijuana and automatically expunging prior criminal 
records for marijuana possession, so those affected don’t have to figure out how to 
petition for it or pay for a lawyer. . . . He would allow states to continue to make their 
own choices regarding legalization and would seek to make it easier to conduct research 
on marijuana’s positive and negative health impacts by rescheduling it as a schedule 2 
drug . . . . 
Max Greenwood, Biden Backs Decriminalizing Marijuana, HILL (May 16, 2019, 3:25 PM), 
https://thehill.com/homenews/campaign/444105-biden-backs-decriminalizing-marijuana 
[https://perma.cc/EC66-YA5D]. 
67 Professor Robert A. Mikos has written extensively in this field. See, e.g., ROBERT A. 
MIKOS, MARIJUANA LAW, POLICY, AND AUTHORITY (2017); Robert A. Mikos, Murphy’s 
Mistake, and How to Fix It, in MARIJUANA FEDERALISM, supra note 6, at 103 (discussing 
preemption concerns); Robert A. Mikos, On the Limits of Supremacy: Medical Marijuana 
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should lead to the question whether states ought to be tasked with such policy 
making. 
Common goals are valuable for supporting robust developments in law. To use 
the example of health reform, a similarly fraught policy space, common goals have 
been challenging to ascertain, with long-standing debate between private market 
advocates and collective-action social reformers as to whether health is a civil right 
in the United States. Yet, broad desire for universal coverage now seems to exist.68 
The common wisdom is that full stakeholder cooperation is needed to achieve any 
law that moves the policy needle meaningfully; a decade ago, this reality played out 
in crafting the ACA, with all industry stakeholders but few political partners coming 
to the table, leading to years of politically motivated litigation.69 Similarly, cannabis 
decriminalization/legalization includes a wide variety of stakeholders and reflects 
their disparate goals, which makes state-based reform both easier (being closer to 
the people) and harder (being subject to capture).70  
Would it be enough for the federal government to lead by example? The 
experience of the ACA and states holding out on Medicaid expansion indicates that 
the answer may be no. States refused expansion as a political matter, to the detriment 
of their health care providers and contrary to evidence that Medicaid expansion 
actually delivers inclusive coverage, better access to care, and improvements in 
underlying determinants of health.71 Deep South and Central Midwest states have 
continued to opt out even during the pandemic, despite the evidence that their 
budgets would stabilize and their people would be healthier if they expanded.72 
Learning from the example of Medicaid expansion, it matters whether and how 
the federal government acts beyond amending the schedules of the CSA. Some 
cannabis advocates seek decriminalization and improvements in criminal justice 
such as automatic expungement for drug-related crimes.73 Others seek new sources 
 
and the States’ Overlooked Power to Legalize Federal Crime, 62 VAND. L. REV. 1419 (2009). 
68 Nicole Huberfeld, Is Medicare for All the Answer? Assessing the Health Reform Gestalt 
as the ACA Turns 10, 20 HOUS. J. HEALTH L. & POL’Y 69, 74 (2020). 
69 See, e.g., Abbe R. Gluck & Nicole Huberfeld, Federalism Under the ACA: 
Implementation, Opposition, Entrenchment, in THE TRILLION DOLLAR REVOLUTION: HOW THE 
AFFORDABLE CARE ACT TRANSFORMED POLITICS, LAW, AND HEALTH CARE IN AMERICA 176, 
180 (Ezekiel J. Emanuel & Abbe R. Gluck eds., 2020). 
70 See supra note 55 and accompanying text (describing Massachusetts bribery scandal). 
71 MADELINE GUTH, RACHEL GARFIELD & ROBIN RUDOWITZ, KAISER FAM. FOUND., THE 




72 Nicole Huberfeld & Sidney Watson, Medicaid’s Vital Role in Addressing Health and 
Economic Emergencies, in ASSESSING LEGAL RESPONSES TO COVID-19, at 103, 104 (Scott 
Burris, Sarah de Guia, Lance Gable, Donna E. Levin, Wendy E. Parmet & Nicolas P. Terry 
eds., 2020), https://static1.squarespace.com/static/5956e16e6b8f5b8c45f1c216/t/5f4d657822 
5705285562d0f0/1598908033901/COVID19PolicyPlaybook_Aug2020+Full.pdf [https:// 
perma.cc/6W53-9RXH]. 
73 E.g., John Washington, He Was Arrested for Marijuana 17 Years Ago. Now It’s Legal. 
So Why Is He Still Guilty of a Crime?, VOX (Dec. 10, 2020, 10:15 AM), 
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of tax revenue to fill state budgetary shortfalls.74 Others want to support or suppress 
a powerful, tobacco-like industry on the rise.75 Some seek economic equity by 
assisting communities harmed by the war on drugs, and others see a chance to 
improve health equity by developing prescription drug safety and efficacy, 
improving pain management, and increasing access to care. Others see potential for 
harm reduction by exploring more deeply the possibilities of cannabis as a mitigating 
feature of substance use disorder treatment.76 Still others want to protect minors, 
seeing parallels to alcohol and tobacco use and the damage they inflict on developing 
biological systems.77 Each of these goals requires more than decriminalization—
they also require novel forms of regulation. 
A health equity lens may provide focus. Public health seeks to minimize risk and 
reduce harm, translating evidence into law and policy that prioritizes underlying 
determinants of health. Disparate enforcement of drug use has measurably harmed 
health by, for example, cutting off needed access to medical care for people targeted 
by law enforcement and overincarcerating populations already disadvantaged by 
structural racism and health disparities both within the criminal justice system and 
in the health care system.78 Federalism as a governance structure continues these 
disparities, allowing state-by-state differences in law that increase risks to health.  
Each of the three major federal bills discussed above recognizes the conflict 
between state and federal law that would continue if Congress amends Schedule I of 
the CSA because, although many states have been on the legalization path, many 
will continue existing criminal regimes. Congress facilitated this problem and should 
address it both at the federal level and by ensuring that states want to engage with 
any shift in federal policy. The Marijuana Justice Act reflects a history-informed 
approach. Many studies show that the nation’s drug policies have caused lasting 
harm, especially for Black people, Indigenous people, and other people of color. 
States have played a major role in these ongoing health disparities. Leaving policy 
choices in the hands of states risks continued health disparities between and within 




74 E.g., Bernie Becker, Cannabis Was Supposed to Be a Tax Windfall for States. The 
Reality Has Been Different., POLITICO: AGENDA (Oct. 14, 2019, 9:44 AM), 
https://www.politico.com/agenda/story/2019/10/14/marijuana-tax-revenue-001062/ [https:// 
perma.cc/EAS3-JRB5]. 
75 See, e.g., Jonah Engel Bromwich, Actually, Maybe Yes, N.Y. TIMES, Nov. 8, 2020, at 
ST1 (noting states are using legalization to “fill coffers in the midst of a pandemic” and, 
observing size of industry that it is building reflects much more than hippie counterculture 
roots opposed by President Nixon). 
76 Honor Whiteman, Marijuana May Help Combat Substance Abuse, Mental Health 
Disorders, MED. NEWS TODAY (Nov. 16, 2016), https://www.medicalnewstoday.com/articles 
/314159 [https://perma.cc/TCQ6-BL4Y]. 
77 See generally Christian Hopfer, Implications of Marijuana Legalization for Adolescent 
Substance Use, 35 SUBSTANCE ABUSE 331 (2014). 
78 See, e.g., Erin Dehon, Nicole Weiss, Jonathan Jones, Whitney Faulconer, Elizabeth 
Hinton & Sarah Sterling, A Systematic Review of the Impact of Physician Implicit Racial Bias 
on Clinical Decision Making, 24 ACAD. EMERGENCY MED. 895 (2017). 
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Congress cannot force states to change their laws, it can do more than amend the 
CSA; for example, it could provide states with more funding to implement equity-
promoting laws and/or withhold prison funding for continued disparate arrests and 
convictions. 
CONCLUSION 
Cultural attitudes regarding cannabis use have shifted significantly in the last 
decade.79 For all the attention given to marijuana policy in recent years, and despite 
the polls indicating broad support for medical marijuana, little about the current 
landscape suggests that health is a primary driver in state policy making. Rather, 
state budgets appear to be.80  
Congress is beginning to take up this fraught question, and the Biden 
Administration may support decriminalization, but some policy makers oppose even 
addressing these issues. Yet, it may be possible to oppose drug use and still to agree 
with the goal of decriminalizing and legalizing cannabis within robust legalization 
regimes.81 The keystone may be underlying determinants of health, as this 
framework is widely accepted to be critical for responding to public health 
challenges.82 Federal funding that supports state change but that does not reduce 
federal funding for discriminatory practices will miss an opportunity to entrench a 
massive federal policy shift through state partnership. The fact that Black 
populations are incarcerated at much greater rates than they represent in the total 
population and that incarceration is a lifelong harm that affects ability to earn stable 
income, accumulate wealth, access health care, attain education, and every other 




79 The popular opinion shift may extend to more drugs than cannabis. See, e.g., Bromwich, 
supra note 75, at ST1 (assessing meaning of successful drug legalization voter initiatives in 
2020 election cycle). 
80 Jeff Chapman, Adam Levin & Alexandria Zhang, Can Revenue from Legalized 
Recreational Marijuana Help States Close Budget Gaps?, PEW TRS. (Dec. 8, 2020), 
https://www.pewtrusts.org/en/research-and-analysis/articles/2020/12/08/can-revenue-from-
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3EDT] (noting that advocates in the four states that legalized cannabis in 2020 touted 
budgetary benefits of new potential source of tax revenue). 
81 John Boehner provides such an example—while he was formerly an opponent of 
legalization, he is now the chairman of the National Cannabis Roundtable. See Bromwich, 
supra note 75, at ST1. 
82 See, e.g., Nabarun Dasgupta, Leo Beletsky & Daniel Ciccarone, Opioid Crisis: No Easy 
Fix to Its Social and Economic Determinants, 108 AM. J. PUB. HEALTH 182, 182 (2018). 
